Last reviewed · How we verify
Group C ("Standard-of-Care")
Group C ("Standard-of-Care") is a Small molecule drug developed by Göteborg University. It is currently FDA-approved.
Group C represents a standard-of-care control arm in a clinical trial, not a specific drug with a defined mechanism of action.
At a glance
| Generic name | Group C ("Standard-of-Care") |
|---|---|
| Sponsor | Göteborg University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This is a trial designation used at Göteborg University to denote the control or comparator group receiving standard treatment for a given condition. Without specification of the actual therapeutic agent or condition being studied, no mechanistic details can be provided. The specific mechanism would depend entirely on what standard-of-care therapy is being used in that particular trial.
Approved indications
Common side effects
Key clinical trials
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer (PHASE1)
- Structured Review: To Optimise Management and Prevent Harm in COPD (NA)
- Effect of Pleuran on the Clinical Course of Patients With Chronic Rhinosinusitis (NA)
- Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia (PHASE2)
- Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients (PHASE2)
- A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant (PHASE1)
- A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D) (NA)
- Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Group C ("Standard-of-Care") CI brief — competitive landscape report
- Group C ("Standard-of-Care") updates RSS · CI watch RSS
- Göteborg University portfolio CI
Frequently asked questions about Group C ("Standard-of-Care")
What is Group C ("Standard-of-Care")?
How does Group C ("Standard-of-Care") work?
Who makes Group C ("Standard-of-Care")?
What development phase is Group C ("Standard-of-Care") in?
Related
- Manufacturer: Göteborg University — full pipeline
- Compare: Group C ("Standard-of-Care") vs similar drugs
- Pricing: Group C ("Standard-of-Care") cost, discount & access